Načítá se...
Drug rechanneling: a novel paradigm for cancer treatment
Cancer continues to be one of the leading contributors towards global disease burden. According to NIH, cancer incidence rate per year will increase to 23.6 million by 2030. Even though cancer continues to be a major proportion of the disease burden worldwide, it has the lowest clinical trial succes...
Uloženo v:
| Vydáno v: | Semin Cancer Biol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7786449/ https://ncbi.nlm.nih.gov/pubmed/32437876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2020.03.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|